11-Dehydrocorticosterone
Based on 2 publication(s) in Google Scholar
11-Dehydrocorticosterone is an orally active 11β-HSD1 substrate and inactive glucocorticoid. 11-Dehydrocorticosterone is reduced by 11β-HSD1 to the active Corticosterone (HY-B1618). 11-Dehydrocorticosterone drives MR-dependent pro-inflammatory stimulation at low/moderate concentrations and GR-dependent suppression after conversion at high concentrations. 11-Dehydrocorticosterone increases Na,K-ATPase subunit mRNA/protein and pump activity in vascular smooth muscle and aorta. 11-Dehydrocorticosterone induces body weight gain, obesity, hyperinsulinemia, and insulin resistance, and inhibits hypothalamic-pituitary-adrenal axis activity. 11-Dehydrocorticosterone can be used in research on hypertension and metabolic syndrome.
For research use only. We do not sell to patients.
- Purity : 96.87%
- CAS No.: 72-23-1
- Formula: C21H28O4
- Molecular Weight:344.44
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) 11-Dehydrocorticosterone
More
Biological Activity
Description
IC50 & Target
|
Human Endogenous Metabolite |
In Vitro
11-Dehydrocorticosterone (50 nM) strongly enhances IL-6-induced 11β-HSD1 mRNA expression in mouse BV-2 microglial cells, whereas inhibition of 11β-HSD1 prevents this effect[1].
11-Dehydrocorticosterone (50 nM) stimulates IL-6 mRNA in mouse BV-2 microglial cells through an 11β-HSD1-dependent mechanism, with the strongest stimulatory effect at approximately 50 nM[1].
11-Dehydrocorticosterone (50 nM) increases IL-6 protein in mouse BV-2 microglial cells after 24 h through 11β-HSD1 and NF-κB-dependent signaling pathways, with the strongest stimulatory effect at approximately 50 nM[1].
11-Dehydrocorticosterone is preferentially converted to corticosterone by 11β-reductase in intact primary late fetal rat hippocampal neurons[3].
11-Dehydrocorticosterone acts as a product inhibitor of 11β-HSD-2[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:murine BV-2 microglial cells
-
Concentration:50 nM
-
Incubation Time:24 h (preincubation)
-
Result:LPS-induced TNF-α mRNA expression was increased, with a somewhat less efficient effect than 25 nM corticosterone.
Relative TNF-α expression was also increased in the absence of LPS.
-
Cell Line:murine BV-2 microglial cells
-
Concentration:50 nM (11-DHC); 10 ng/mL (LPS); 1 μM (T0504); 250 nM (Cay-10512); about 50 nM (peak concentration-response); >250 nM (suppression)
-
Incubation Time:24 h
-
Result:At 50 nM, IL-6 protein expression was increased, and the increase was blocked by 1 μM T0504.
In the absence of LPS, IL-6 expression was also enhanced at 50 nM.
A biphasic IL-6 protein response occurred with peak stimulation at about 50 nM and suppression at concentrations higher than 250 nM.
Cay-10512 at 250 nM diminished IL-6 production stimulated at 50 nM.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 200-250 g)[2]
-
Dosage:1 mg/kg body wt
-
Administration:s.c.; single injection; 12 hours before tissue collection
-
Result:In adrenalectomized rats, aorta α1-mRNA levels increased 3.4-fold and β1-mRNA levels increased 8.4-fold.
-
Animal Model:C57BL/6J (male)[8]
-
Dosage:25 µg/mL and 50 µg/mL
-
Administration:p.o.; drinking water; 5 weeks
-
Result:At 25 and 50 µg/mL, circulating corticosterone increased at nadir and peak in a dose-dependent manner.
Both doses decreased adrenal gland weight, circulating ACTH at nadir and peak, and POMC.
At 50 µg/mL, percentage body weight and body weight gain increased by day 28, food intake increased, and epididymal fat pad mass increased; mesenteric and subcutaneous fat pad masses were also increased.
At 50 µg/mL, fasting insulin and insulin excursion after oral glucose increased and HOMA-IR increased, with no difference in glucose excursion during the OGTT.
The 25 µg/mL group showed a trend toward increased fasting insulin and insulin excursion.
Chemical Information
-
CAS No. 72-23-1
-
Appearance Solid
-
Molecular Weight 344.44
-
Formula C21H28O4
-
Color White to off-white
-
SMILES
C[C@@]1(C2)[C@@H](C(CO)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])C2=O)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
J Ethnopharmacol
Glycyrrhizic acid and patchouli alcohol in Huoxiang Zhengqi attenuate intestinal inflammation and barrier injury via regulating endogenous corticosterone metabolism mediated by 11β-HSD1. [Abstract]2025 Feb 10;338(Pt 1):119025. PMID: 39489360 -
Purity & Documentation
-
Data Sheet (298 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chantong B, et al. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. Journal of neuroinflammation. 2012 Nov 28;9:260. [Content Brief]
[6]. Sheppard KE, et al. 11β-Hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart. Endocrinology. 2002 Jan 1;143(1):198-204. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- 11-Dehydrocorticosterone
- 72-23-1
- 11β-HSD
- Drug Intermediate
- Na+/K+ ATPase
- 11beta-HSD
- 11β-hydroxysteroid dehydrogenases
- 11 beta-hydroxysteroid dehydrogenase
- Drug Iintermediate
- Sodium potassium pump
- 11β-HSD1
- 11β-HSD2
- IL-6
- NF-κB
- Na,K-ATPase
- SGK
- TNFR2
- glucocorticoid receptor
- metabolic syndrome
- mineralocorticoid receptor
- Inhibitor
- inhibitor
- inhibit